FindMyKOL
Clinical trialNCT05671887RecruitingObservational

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

NCT05671887 is an observational study sponsored by Northwestern University. As of 21 Nov 2026, it is recruiting participants. It studies Bilateral Cancer, Lung Cancer and 1 more condition. The registry lists an enrollment of 125 participants at 1 site in 1 country. The registry lists a start date of 16 Nov 2022 and a primary completion date of 30 Nov 2032.

SponsorNorthwestern University →Enrollment125Bilateral CancerLung CancerLung Transplant
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05671887
FieldValue
Registry IDNCT05671887
StatusRecruiting
Study typeObservational study
Lead sponsorNorthwestern University
Enrollment125
Registered sites1
Countries1
ConditionsBilateral Cancer, Lung Cancer and Lung Transplant
Start16 Nov 2022
Primary completion30 Nov 2032
Study completion30 Nov 2032
Last update posted21 Oct 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a prospective observational registration trial for patients who undergo lung transplantation for the treatment of the select groups of medically refractory cancers affecting the lungs alone without extrapulmonary nodal and distant metastasis.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Illinois, United States1 site, 1 recruiting
  • Thoracic Surgery, Canning Thoracic Institute (northwestern Memorial Hospital)

    Chicago

    Ankit Bharat, MDRade Tomic, MDYoung Chae, MD MPH MBA
    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinois: 1 site, 1 recruitingIL1IndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05671887

Each answer restates registry values shown on this page.

What is NCT05671887?

NCT05671887 is an observational study sponsored by Northwestern University. It studies Bilateral Cancer, Lung Cancer and 1 more condition.

Is NCT05671887 recruiting?

As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.

Who leads NCT05671887?

The registry names Ankit Bharat, MD (principal investigator, Northwestern University), Rade Tomic, MD (principal investigator, Northwestern University) and Young Chae, MD MPH MBA (principal investigator, Northwestern University) as overall officials.

Where does NCT05671887 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT05671887 expected to complete?

The registry lists a primary completion date of 30 Nov 2032 and a study completion date of 30 Nov 2032. The sponsor last updated the record on 21 Oct 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.